Dassault Systèmes Presents ‘Licence to cure' for the compliance of medical devices

Dassault Systèmes launches of a new solution of industrial experience for the manufacturers of medical devices, designated ‘Licence to cure' (Licensed to Cure). Based in the platform 3DExperience of Dassault Systèmes, help to accelerate the supply of innovative medical devices, insurance and fully satisfied to the legislation.

The experience of industrial solution ‘Licence to cure' guarantees an only source of information for the innovation, as well as a process of change totally transparent and fully documented, allowing to the manufacturers of medical devices optimise the allocation of resources, maximizar the reuse of copyright and racionalizar the process of presentation and statement in front of the regulators. By means of the creation of a process of development of products of point ready, trazable and satisfied that is directly linked to the gestión of quality, the manufacturers of medical devices can accelerate the arrival to the market and minimise the load regulatoria.

Launched during the conference AdvaMed 2012, the experience of industrial solution ‘Licence to cure' allows to the companies to delete the processes and data fragmentados, and ‘integrate' the regulations like an active, optimising the quality and the normative fulfillment and reducing the costs and the time of arrival to the market. Likewise it guarantees an only source of information that allows to the manufacturers obtain always notable and up to date information, and establish a true collaboration on the same group of precise data of product. It automates bureaucratic ‘tasks' and guarantees the application of the procedure that drives to the correct manufacture of products to the first, accelerating the time of approval regulatoria. It provides a process and documentation structured, like the DHF and DMR ‘live', for a complete trazabilidad and a reporting and archive automated. Also it helps to the manufacturers of medical devices to accelerate and increase the line of innovation to sustain the expansion of market in new countries and with skilled products to satisfy the needs of the patients without pertinent limits of the mitigación of risks or the normative restrictions. Finally, it optimises the chain of supply of the manufacturers of medical devices and his widespread ecosystem, to reduce the risks of normative compliance and quality, guaranteeing at the same time the value of the mark and the image in front of the consumers.